Radius Health

-$0.10 (-0.63%) As of 7:50 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Radius Health and other ETFs, options, and stocks.

About RDUS

Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis.

CEO
George Kelly Martin
Employees
310
Headquarters
Boston, Massachusetts
Founded
2003

RDUS Key Statistics

Market Cap
870.38M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
320.39K
High Today
$15.38
Low Today
$15.01
Open Price
$15.33
Volume
182.14K
52 Week High
$26.16
52 Week Low
$10.15

RDUS Earnings

-$0.77
-$0.46
-$0.16
$0.15
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 5, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure